Yes, I Partnered With a Skincare Company. Here Is Why.
Yes, I partnered with a skincare company. Introducing Codex Labs.
In 1996 I went through radiation as part of my post operative brain cancer treatment. The machine burned through tissue fast. The recovery plan for my skin amounted to petroleum jelly and good luck. No clinician discussed barrier function. No one tracked long term dermal damage. The system treated skin breakdown as collateral damage inside a larger billing code.
That pattern persists.
Dermatology guidelines still rely heavily on topical steroids for inflammatory disease because they reduce symptoms quickly and insurers reimburse them predictably. The Food and Drug Administration regulates most skincare products as cosmetics rather than therapeutic agents, which means companies sell formulations without proving long term safety before they reach patients. The burden shifts to the consumer after harm appears. Parents and patients then study ingredient lists at midnight while institutions document adverse events months later.
I partnered with Codex Labs because they focus on barrier integrity and microbiome science for compromised skin, including people in active cancer treatment. They formulate without fragrance driven marketing strategies and without chemical clutter designed to impress rather than protect. I care about skin health for the same reason I care about any other survivorship issue. Treatment leaves residue. Institutions move on. Patients live with the aftermath.
I use their products. My family uses them. I would hand them to another cancer patient without hesitation. That threshold governs every endorsement I make.
